BMC Medical Co. Ltd. A Total Assets
BMC Medical Co. Ltd. A total assets. Based on the latest financial reports, BMC Medical Co. Ltd. A (301367) holds total assets worth CN¥3.59 Billion CNY (≈ $524.90 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 301367 market cap for the company's overall valuation and market capitalisation.
Total Assets of BMC Medical Co. Ltd. A (2020–2025)
Total assets of BMC Medical Co. Ltd. A from 2020 to 2025. This chart illustrates how BMC Medical Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See BMC Medical Co. Ltd. A share price for real-time trading data and today's change.
BMC Medical Co. Ltd. A - Asset Composition Analysis
BMC Medical Co. Ltd. A Total Assets Breakdown (December 2025)
BMC Medical Co. Ltd. A total assets breakdown as of December 2025. BMC Medical Co. Ltd. A's total assets of CN¥3.59 Billion consist of 90.4% current assets and 9.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 31.6% |
| Accounts Receivable | CN¥241.77 Million | 7.1% |
| Inventory | CN¥115.79 Million | 3.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥34.03 Million | 1.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how BMC Medical Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BMC Medical Co. Ltd. A (301367) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BMC Medical Co. Ltd. A's current assets represent 90.4% of total assets in 2025, a decrease from 93.1% in 2020.
- Cash Position: Cash and equivalents constituted 31.6% of total assets in 2025, down from 46.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 7.1% of total assets.
BMC Medical Co. Ltd. A Competitors by Total Assets
Key competitors of BMC Medical Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
BMC Medical Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.28 | 5.57 | 29.19 |
| Quick Ratio | 5.87 | 5.38 | 27.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.68 Billion | CN¥2.66 Billion | CN¥2.69 Billion |
BMC Medical Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between BMC Medical Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.79 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | -1.2% |
| Total Assets | CN¥3.38 Billion |
| Market Capitalization | $736.99 Million USD |
Valuation Analysis
Below Book Valuation: The market values BMC Medical Co. Ltd. A's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: BMC Medical Co. Ltd. A's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for BMC Medical Co. Ltd. A (2020–2025)
The table below shows the annual total assets of BMC Medical Co. Ltd. A from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.38 Billion ≈ $495.33 Million |
-1.16% |
| 2024-12-31 | CN¥3.42 Billion ≈ $501.16 Million |
+17.35% |
| 2023-12-31 | CN¥2.92 Billion ≈ $427.07 Million |
-0.28% |
| 2022-12-31 | CN¥2.93 Billion ≈ $428.28 Million |
+369.26% |
| 2021-12-31 | CN¥623.69 Million ≈ $91.27 Million |
+33.37% |
| 2020-12-31 | CN¥467.64 Million ≈ $68.43 Million |
-- |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China and internationally. The company offers home-use non-invasive ventilators, ventilation masks, sleep monitors, high-flow humidified oxygen therapy devices, and oxygen concentrators. It also provides chronic disease management services for respiratory h… Read more